Daré Bioscience furnishes corporate presentation for investor meetings on June 22, 2026

Dare Bioscience, Inc.

Presentation available in the Investors section of company website.
No specific financial or clinical data from presentation disclosed in this 8-K.
Company will use presentation in meetings with securities market participants.

item 7.01 item 9.01

Dare Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-029515

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.